The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Prevalence of Muscular Dystrophies: A Systematic Literature Review
Open accessAbstract
Background: Determining the prevalence of neuromuscular disorders for the general population is important to identify the scope of burden on society and enable comparisons with other health conditions. This systematic review aims to identify and collate the findings of studies published between 1960 and 2013 on the prevalence of all types of muscular dystrophies. Summary: Relevant articles were identified through electronic database searches and manual searches of reference lists. There were 38 articles from across 19 countries that met the inclusion criteria. The total combined prevalence for all muscular dystrophies for studies classified as having a low risk of bias ranged between 19.8 and 25.1 per 100,000 person-years. Myotonic dystrophy (0.5-18.1 per 100,000), Duchenne muscular dystrophy (1.7-4.2) and facioscapulohumeral muscular dystrophy (3.2-4.6 per 100,000) were found to be the most common types of disorder. There was wide variation in study methodology, case ascertainment, and verification procedures and populations studied, all of which may contribute to the wide prevalence range, in addition to the likely variation in prevalence by country. Key Messages: Greater consistency in the conduct and reporting of neuroepidemiological studies is urgently needed to enable comparisons to be made between studies, countries, and over time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bushby, K., Finkel, R., Birnkrant, D. J., Case, L. E., Clemens, P. R., Cripe, L., Kaul, A., Kinnett, K., McDonald, C., Pandya, S., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70271-6 · Cited by 2,053
Population frequencies of inherited neuromuscular diseases—A world survey
Emery, A. E. H. (1991) · Neuromuscular Disorders · doi:10.1016/0960-8966(91)90039-u · Cited by 1,448
Eagle, M., Baudouin, S. V., Chandler, C., Giddings, D. R., Bullock, R., & Bushby, K. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00140-2 · Cited by 1,009
Ruano, L., Melo, C., Silva, M. C., & Coutinho, P. (2014) · Neuroepidemiology · doi:10.1159/000358801 · Cited by 683
Wirth, B. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200003)15:3<228::aid-humu3>3.0.co;2-9 · Cited by 667
Systematics and the Origin of Species from the Viewpoint of a Zoologist
Schmidt, K. P., & Mayr, E. (1943) · Copeia · doi:10.2307/1438628 · Cited by 660
Norwood, F. L. M., Harling, C., Chinnery, P. F., Eagle, M., Bushby, K., & Straub, V. (2009) · Brain · doi:10.1093/brain/awp236 · Cited by 541
ON THE CLASSIFICATION, NATURAL HISTORY AND TREATMENT OF THE MYOPATHIES
WALTON, J. N., & NATTRASS, F. J. (1954) · Brain · doi:10.1093/brain/77.2.169 · Cited by 541
Prevalence of mitochondrial DNA disease in adults
Schaefer, A. M., McFarland, R., Blakely, E. L., He, L., Whittaker, R. G., Taylor, R. W., Chinnery, P. F., & Turnbull, D. M. (2008) · Annals of Neurology · doi:10.1002/ana.21217 · Cited by 494
Cited by
Birnkrant, D. J., Bushby, K., Bann, C. M., Apkon, S. D., Blackwell, A., Brumbaugh, D., Case, L. E., Clemens, P. R., Hadjiyannakis, S., Pandya, S., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30024-3 · Cited by 1,370
Duan, D., Goemans, N., Takeda, S., Mercuri, E., & Aartsma-Rus, A. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00248-3 · Cited by 1,312
Birnkrant, D. J., Bushby, K., Bann, C. M., Alman, B. A., Apkon, S. D., Blackwell, A., Case, L. E., Cripe, L., Hadjiyannakis, S., Olson, A. K., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30025-5 · Cited by 1,167
Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease
Gorman, G. S., Schaefer, A. M., Ng, Y., Gomez, N., Blakely, E. L., Alston, C. L., Feeney, C., Horvath, R., Yu‐Wai‐Man, P., Chinnery, P. F., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24362 · Cited by 936
Cirak, S., Arechavala-Gomeza, V., Guglieri, M., Feng, L., Torelli, S., Anthony, K., Abbs, S., Garralda, M. E., Bourke, J., Wells, D. J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60756-3 · Cited by 878
A systematic review of population based epidemiological studies in Myasthenia Gravis
Carr, A. S., Cardwell, C. R., McCarron, P. O., & McConville, J. (2010) · BMC Neurology · doi:10.1186/1471-2377-10-46 · Cited by 756
Verhaart, I. E. C., Robertson, A., Wilson, I. J., Aartsma-Rus, A., Cameron, S., Jones, C. C., Cook, S. F., & Lochmüller, H. (2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-017-0671-8 · Cited by 739
The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations
Bladen, C. L., Salgado, D., Monges, S., Foncuberta, M. E., Kekou, K., Kosma, K., Dawkins, H., Lamont, L., Roy, A. J., Chamova, T., et al. (2015) · Human Mutation · doi:10.1002/humu.22758 · Cited by 729
Self-citationSkeletal muscle: A review of molecular structure and function, in health and disease
Mukund, K., & Subramaniam, S. (2020) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1462 · Cited by 664
Epidemiology of peripheral neuropathy.
Martyn, C. N., & Hughes, R. A. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.4.310 · Cited by 597
Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development
Dhuri, K., Bechtold, C., Quijano, E., Pham, H., Gupta, A., Vikram, A., & Bahal, R. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9062004 · Cited by 545
The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review
Ryder, S., Leadley, R. M., Armstrong, N., Westwood, M., de Kock, S., Butt, T., Jain, M., & Kleijnen, J. (2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-017-0631-3 · Cited by 530
Mendell, J. R., Goemans, N., Lowes, L. P., Alfano, L. N., Berry, K., Shao, J., Kaye, E. M., Mercuri, E., & for the Eteplirsen Study Group and Telethon Foundation DMD Italian Network (2016) · Annals of Neurology · doi:10.1002/ana.24555 · Cited by 518
Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy
Duan, D. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.07.011 · Cited by 489
Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis
Crisafulli, S., Sultana, J., Fontana, A., Salvo, F., Messina, S., & Trifirò, G. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01430-8 · Cited by 500
Corticosteroids for the treatment of Duchenne muscular dystrophy
Matthews, E., Brassington, R., Kuntzer, T., Jichi, F., & Manzur, A. Y. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003725.pub4 · Cited by 493
Natural history of denervation in SMA: Relation to age, SMN2 copy number, and function
Swoboda, K. J., Prior, T. W., Scott, C. B., McNaught, T. P., Wride, M. C., Reyna, S. P., & Bromberg, M. B. (2005) · Annals of Neurology · doi:10.1002/ana.20473 · Cited by 478
Birnkrant, D. J., Bushby, K., Bann, C. M., Apkon, S. D., Blackwell, A., Colvin, M. K., Cripe, L., Herron, A. R., Kennedy, A., Kinnett, K., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30026-7 · Cited by 470
The Dystrophin Complex: Structure, Function, and Implications for Therapy
Gao, Q. Q., & McNally, E. M. (2015) · Comprehensive Physiology · doi:10.1002/cphy.c140048 · Cited by 456
Talbot, J., & Maves, L. (2016) · WIREs Developmental Biology · doi:10.1002/wdev.230 · Cited by 437
Ataluren treatment of patients with nonsense mutation dystrophinopathy
Bushby, K., Finkel, R., Wong, B., Barohn, R., Campbell, C., Comi, G. P., Connolly, A. M., Day, J. W., Flanigan, K. M., Goemans, N., et al. (2014) · Muscle & Nerve · doi:10.1002/mus.24332 · Cited by 428
Self-citationNon-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities
Li, L., Hu, S., & Chen, X. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.04.031 · Cited by 415
Duchenne muscular dystrophy: Pathogenetic aspects and genetic prevention
Moser, H. (1984) · Human Genetics · doi:10.1007/bf00275183 · Cited by 413
Thornton, C. A. (2014) · Neurologic Clinics · doi:10.1016/j.ncl.2014.04.011 · Cited by 377
The importance of genetic diagnosis for Duchenne muscular dystrophy
Aartsma-Rus, A., Ginjaar, I. B., & Bushby, K. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103387 · Cited by 369
A guide for the diagnosis of rare and undiagnosed disease: beyond the exome
Marwaha, S., Knowles, J. W., & Ashley, E. A. (2022) · Genome Medicine · doi:10.1186/s13073-022-01026-w · Cited by 359
Morrow, J. M., Sinclair, C. D. J., Fischmann, A., Machado, P. M., Reilly, M. M., Yousry, T. A., Thornton, J. S., & Hanna, M. G. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00242-2 · Cited by 342
Diagnostic approach to the congenital muscular dystrophies
Bönnemann, C. G., Wang, C. H., Quijano-Roy, S., Deconinck, N., Bertini, E., Ferreiro, A., Muntoni, F., Sewry, C., Béroud, C., Mathews, K. D., et al. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.12.011 · Cited by 340
Maffioletti, S. M., Sarcar, S., Henderson, A. B. H., Mannhardt, I., Pinton, L., Moyle, L. A., Steele-Stallard, H., Cappellari, O., Wells, K. E., Ferrari, G., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.091 · Cited by 337
Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy
Frank, D. E., Schnell, F. J., Akana, C., El-Husayni, S. H., Desjardins, C. A., Morgan, J., Charleston, J. S., Sardone, V., Domingos, J., Dickson, G., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009233 · Cited by 332
Kozakowska, M., Pietraszek-Gremplewicz, K., Jozkowicz, A., & Dulak, J. (2015) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-015-9438-9 · Cited by 331
The epidemiology of Huntington's disease
Harper, P. (1992) · Human Genetics · doi:10.1007/bf00194305 · Cited by 328
Contemporary Cardiac Issues in Duchenne Muscular Dystrophy
McNally, E. M., Kaltman, J. R., Benson, D. W., Canter, C. E., Cripe, L. H., Duan, D., Finder, J. D., Groh, W. J., Hoffman, E. P., Judge, D. P., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.015151 · Cited by 326
Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis
Marin, B., Boumédiene, F., Logroscino, G., Couratier, P., Babron, M.-C., Leutenegger, A. L., Copetti, M., Preux, P.-M., & Beghi, E. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw061 · Cited by 325
Centronuclear (myotubular) myopathy
Jungbluth, H., Wallgren-Pettersson, C., & Laporte, J. (2008) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-3-26 · Cited by 321
Drosophila as an In Vivo Model for Human Neurodegenerative Disease
McGurk, L., Berson, A., & Bonini, N. M. (2015) · Genetics · doi:10.1534/genetics.115.179457 · Cited by 318
Role of Pericytes in Skeletal Muscle Regeneration and Fat Accumulation
Birbrair, A., Zhang, T., Wang, Z.-M., Messi, M. L., Enikolopov, G. N., Mintz, A., & Delbono, O. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0647 · Cited by 307
Polyglutamine Repeats in Neurodegenerative Diseases
Lieberman, A. P., Shakkottai, V. G., & Albin, R. L. (2019) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012857 · Cited by 304
Mcdonald, C. M., Henricson, E. K., Abresch, R. T., Florence, J. M., Eagle, M., Gappmaier, E., Glanzman, A. M., PTC124‐GD‐007‐DMD Study Group, Spiegel, R., Barth, J., et al. (2013) · Muscle & Nerve · doi:10.1002/mus.23902 · Cited by 303
Epigenetic principles and mechanisms underlying nervous system functions in health and disease
MEHLER, M. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.10.001 · Cited by 291
Rafehi, H., Szmulewicz, D. J., Bennett, M. F., Sobreira, N. L. M., Pope, K., Smith, K. R., Gillies, G., Diakumis, P., Dolzhenko, E., Eberle, M. A., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.05.016 · Cited by 262
Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy
Hathout, Y., Brody, E., Clemens, P. R., Cripe, L., DeLisle, R. K., Furlong, P., Gordish-Dressman, H., Hache, L., Henricson, E., Hoffman, E. P., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507719112 · Cited by 290
Prevalence of Duchenne and Becker Muscular Dystrophies in the United States
Romitti, P. A., Zhu, Y., Puzhankara, S., James, K. A., Nabukera, S. K., Zamba, G. K. D., Ciafaloni, E., Cunniff, C., Druschel, C. M., Mathews, K. D., et al. (2015) · Pediatrics · doi:10.1542/peds.2014-2044 · Cited by 290
The powerful world of antisense oligonucleotides: From bench to bedside
Quemener, A. M., Bachelot, L., Forestier, A., Donnou‐Fournet, E., Gilot, D., & Galibert, M. (2020) · WIREs RNA · doi:10.1002/wrna.1594 · Cited by 280
Overview of the Muscle Cytoskeleton
Henderson, C. A., Gomez, C. G., Novak, S. M., Mi‐Mi, L., & Gregorio, C. C. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c160033 · Cited by 278
Profiling the genome-wide landscape of tandem repeat expansions
(2019) · doi:10.1093/nar/gkz501 · Cited by 270
Correa-de-Araujo, R., Harris-Love, M. O., Miljkovic, I., Fragala, M. S., Anthony, B. W., & Manini, T. M. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00087 · Cited by 268
Deep Intronic FGF14 GAA Repeat Expansion in Late-Onset Cerebellar Ataxia
Pellerin, D., Danzi, M. C., Wilke, C., Renaud, M., Fazal, S., Dicaire, M.-J., Scriba, C. K., Ashton, C., Yanick, C., Beijer, D., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2207406 · Cited by 260
Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy
Amoasii, L., Long, C., Li, H., Mireault, A. A., Shelton, J. M., Sanchez-Ortiz, E., McAnally, J. R., Bhattacharyya, S., Schmidt, F., Grimm, D., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan8081 · Cited by 247
Tawil, R., Kissel, J. T., Heatwole, C., Pandya, S., Gronseth, G., & Benatar, M. (2015) · Neurology · doi:10.1212/wnl.0000000000001783 · Cited by 234
Hohenfeld, C., Werner, C. J., & Reetz, K. (2018) · NeuroImage: Clinical · doi:10.1016/j.nicl.2018.03.013 · Cited by 232
Carlier, P. G., Marty, B., Scheidegger, O., Loureiro de Sousa, P., Baudin, P.-Y., Snezhko, E., & Vlodavets, D. (2016) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-160145 · Cited by 186
Hall, T. E., Bryson-Richardson, R. J., Berger, S., Jacoby, A. S., Cole, N. J., Hollway, G. E., Berger, J., & Currie, P. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700942104 · Cited by 178
Practical recommendations to conduct a neuroimaging meta-analysis for neuropsychiatric disorders
Tahmasian, M., Sepehry, A. A., Samea, F., Khodadadifar, T., Soltaninejad, Z., Javaheripour, N., Khazaie, H., Zarei, M., Eickhoff, S. B., & Eickhoff, C. R. (2019) · Human Brain Mapping · doi:10.1002/hbm.24746 · Cited by 126
Facioscapulohumeral Muscular Dystrophy
Statland, J. M., & Tawil, R. (2016) · Continuum · doi:10.1212/con.0000000000000399 · Cited by 121
Ma, N., Chen, D., Lee, J.-H., Kuri, P., Hernandez, E. B., Kocan, J., Mahmood, H., Tichy, E. D., Rompolas, P., & Mourkioti, F. (2022) · Science Advances · doi:10.1126/sciadv.abn0485 · Cited by 118
D'Amore, A., Tessa, A., Casali, C., Dotti, M. T., Filla, A., Silvestri, G., Antenora, A., Astrea, G., Barghigiani, M., Battini, R., et al. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00981 · Cited by 90
Kuno, A., Hosoda, R., Sebori, R., Hayashi, T., Sakuragi, H., Tanabe, M., & Horio, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-33930-w · Cited by 88
Patient-Reported Symptoms in Facioscapulohumeral Muscular Dystrophy (PRISM-FSHD)
Hamel, J., Johnson, N., Tawil, R., Martens, W. B., Dilek, N., McDermott, M. P., & Heatwole, C. (2019) · Neurology · doi:10.1212/wnl.0000000000008123 · Cited by 88
Direct reprogramming of urine-derived cells with inducible MyoD for modeling human muscle disease
Kim, E. Y., Page, P., Dellefave-Castillo, L. M., McNally, E. M., & Wyatt, E. J. (2016) · Skeletal Muscle · doi:10.1186/s13395-016-0103-9 · Cited by 43
Grigsby, J. (2016) · The Clinical Neuropsychologist · doi:10.1080/13854046.2016.1184652 · Cited by 34
Exercise prevents impaired autophagy and proteostasis in a model of neurogenic myopathy
Campos, J. C., Baehr, L. M., Gomes, K. M. S., Bechara, L. R. G., Voltarelli, V. A., Bozi, L. H. M., Ribeiro, M. A. C., Ferreira, N. D., Moreira, J. B. N., Brum, P. C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-30365-1 · Cited by 32
Rose, M., Graham, C. D., O'Connell, N., Vari, C., Edwards, V., Taylor, E., McCracken, L. M., Radunovic, A., Rakowicz, W., Norton, S., et al. (2023) · Psychological Medicine · doi:10.1017/s0033291722000083 · Cited by 28
Spaulding, H. R., Ludwig, A. K., Hollinger, K., Hudson, M. B., & Selsby, J. T. (2020) · Physiological Reports · doi:10.14814/phy2.14383 · Cited by 23
Amelioration of Muscle and Nerve Pathology in LAMA2 Muscular Dystrophy by AAV9-Mini-Agrin
Qiao, C., Dai, Y., Nikolova, V. D., Jin, Q., Li, J., Xiao, B., Li, J., Moy, S. S., & Xiao, X. (2018) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2018.01.005 · Cited by 23
Bencze, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010362 · Cited by 20
Rose, M. R., Norton, S., Vari, C., Edwards, V., McCracken, L., Graham, C. D., Radunovic, A., & Chalder, T. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-022083 · Cited by 15
Matos-Pina, I., Trindade, I. A., & Ferreira, C. (2022) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-022-09855-y · Cited by 8
Metadata
- Authors
- Theadom, A., Rodrigues, M., Roxburgh, R., Balalla, S., Higgins, C., Bhattacharjee, R., Jones, K., Krishnamurthi, R., & Feigin, V.
- Venue
- Neuroepidemiology
- Publisher
- S. Karger AG
- Published
- 2014
- Volume
- 43
- Issue
- 3-4
- Pages
- 259-268
- ISSN
- 0251-5350 (ISSN-L)
- 1423-0208
- OpenAlex
- W2020685420
- Cited by
- 2,046
- References
- 134
- FWCI
- 10.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.